Olanzapine vs haloperidol for treatment of schizophrenia.
Lieuwe
L
de Haan
Nico
N
van Beveren
D017109:Akathisia, Drug-Induced / Q000517:prevention & control; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines / Q000008:administration & dosage*; D001590:Benztropine / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D006220:Haloperidol / Q000008:administration & dosage*; D006801:Humans; D000077152:Olanzapine; D017448:Receptors, Dopamine D2; D012559:Schizophrenia / Q000188:drug therapy*
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D017448:Receptors, Dopamine D2; D001569:Benzodiazepines; D001590:Benztropine; D006220:Haloperidol; D000077152:Olanzapine